Company / R&D Expense
ADC Therapeutics SA R&D Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$104.0M
FY2025
5-year range
$104.0M / $186.5M
FY2023-FY2025
Trend
-18.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $186M to $104M over the past 2 years.
Based on SEC 10-K filings.
$104M in FY2025.
Declined from $186M to $104M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d expense decreased 18.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $104.0M | -18.2% |
| FY2024 | $127.1M | -31.8% |
| FY2023 | $186.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026